WallStSmart
NRSN

Neurosense Therapeutics Ltd

NASDAQ: NRSN · HEALTHCARE · BIOTECHNOLOGY

$0.80
-0.72% today

Updated 2026-04-29

Market cap
$26.53M
P/E ratio
P/S ratio
EPS (TTM)
$-0.44
Dividend yield
52W range
$1 – $3
Volume
0.2M

Neurosense Therapeutics Ltd (NRSN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+50.7%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+10.0%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+14.4%
2025-11-26
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-25$0.00+100.0%$0.73$0.77+5.5%
2025-11-26$-0.04+27.3%$1.04$1.19+14.4%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.11$0.00+100.0%
2025-09-30$-0.06$-0.04+27.3%
2025-06-30$-0.23$-0.19+15.6%
2025-03-31$-0.15$-0.06+60.0%
2024-12-31$-0.15$-0.06+60.0%
2024-09-30$-0.11$-0.11+0.0%
2024-06-30$-0.19$-0.05+73.0%
2024-03-31$-0.20$-0.35-75.0%
2023-12-31$-0.20$-0.16+20.0%
2023-09-30$-0.24$0.10+141.7%
2023-06-30$-0.28$-0.44-57.1%
2023-03-31$-0.29$-0.33-13.8%

Frequently asked questions

Has Neurosense Therapeutics Ltd beaten earnings estimates?
Neurosense Therapeutics Ltd has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +50.7% over the last 4 quarters.
How does NRSN stock react to earnings?
NRSN stock has moved an average of +10.0% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.